This tactical session unpacks how rebate guarantees, GPO deals, and pass-through arrangements can obscure the true cost of your pharmacy spend. We’ll break down how rebate mechanics shape formulary design, what employers are earning (or losing) on rebates, and what audit, RFP, or renegotiation strategies you can use to regain transparency.
GLP-1s are dominating headlines—and your pharmacy budget. But how do you cover these high-cost drugs responsibly? This session delivers practical tools for integrating GLP-1 coverage with behavioral and lifestyle supports, from BMI-based guardrails to coaching models and clinical adherence programs. Learn how to strike the right balance between access, outcomes, and cost.
Pharmacy benefit decisions involve a complex network of players—including PBMs, consultants, and coalitions. This session helps employers identify where incentives may be misaligned, what questions to ask, and how to ensure transparency and accountability—without pointing fingers. You'll leave with practical tools to manage fiduciary responsibilities and strengthen your pharmacy strategy.
Specialty drugs continue to dominate pharmacy spend and complicate benefit decisions. Grounded in employer perspective market research and real-world data, this session shows how to translate pipeline intelligence into action. Learn how employers can anticipate emerging therapies, forecast budget impact, and apply clinical strategies that balance affordability with outcomes.
